Director Shareholding

RNS Number:2011H
GW Pharmaceuticals PLC
19 July 2001

                                 SCHEDULE 11

         NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS


 1. Name of Company

    G W Pharmaceuticals plc

 2. Name of Director

    Dr Brian Anthony Whittle

 3. Please state whether notification indicates that it is in respect of
    holding of the shareholder named in 2 above or in respect of a
    non-beneficial interest or in the case of an individual holder if it is a
    holding of that person's spouse or children under the age of 18 or in
    respect of a non-beneficial interest

    Beneficial interest in respect of 2 above

 4. Name of the registered holder(s) and, if more than one holder, the number
    of shares held by each of them (if notified)

    Brian Whittle Associates Limited

 5. Please state whether notification relates to a person(s) connected with the
    Director named in 2 above and identify the connected person(s)

    As 2 above

 6. Please state the nature of the transaction. For PEP transactions please
    indicate whether general/single co PEP and if discretionary/non
    discretionary

    Purchase

 7. Number of shares/amount of stock acquired

    50,000

 8. Percentage of issued class

    0.052%

 9. Number of shares/amount of stock disposed

    N/A

10. Percentage of issued class

    N/A

11. Class of security

    Ordinary Shares

12. Price per share

    #1.24p

13. Date of transaction

    17th July 2001

14. Date company informed

    19th July 2001

15. Total holding following this notification

    11,545,446

16. Total percentage holding of issued class following this notification

    12.02%

    If a director has been granted options by the company please complete the
    following boxes

17. Date of grant





18. Period during which or date on which exercisable





19. Total amount paid (if any) for grant of the option





20. Description of shares or debentures involved: class, number





21. Exercise price (if fixed at time of grant) or indication that price is to
    be fixed at time of exercise





22. Total number of shares or debentures over which options held following
    this notification





23. Any additional information





24. Name of contact and telephone number for queries

    Justin Gover, 01980 557 000

25. Name and signature of authorised company official responsible for making
    this notification

Justin Gover, Managing Director



Date of Notification: 19th July 2001